Current Concepts in the Management of Relapsed/Refractory Multiple Myeloma: Considerations With Bispecific Anti-BCMA Antibodies
This activity is designed to meet the educational needs of community-based oncologists, hematologists, hematology pharmacists, nurse practitioners, and physician’s assistants to ensure confidence in the management of relapsed/refractory multiple myeloma.
RELEASED DATE: May 01, 2023
EXPIRATION DATE: May 31, 2024